THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL-ALLOGRAFT SURVIVAL (T1/2)

被引:370
作者
MATAS, AJ [1 ]
GILLINGHAM, KJ [1 ]
PAYNE, WD [1 ]
NAJARIAN, JS [1 ]
机构
[1] UNIV MINNESOTA HOSP & CLIN,DEPT SURG,MINNEAPOLIS,MN 55455
关键词
D O I
10.1097/00007890-199403270-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An acute renal transplant rejection episode has been shown to be associated with decreased 1-year graft survival. The impact on long-term outcome is undefined. We studied the impact of an acute rejection episode on t1/2, the time it takes for 1/2 of the grafts functioning at 1 year to fail. Use of t1/2 avoids inclusion of early graft loss to acute rejection or complications of treatment. Since 1/1/86, a total of 653 patients have received a primary kidney transplant and had at least 1 year of function. Recipients were divided by the incidence and timing of rejection: no rejection; 1 rejection within the first year, >1 rejection, the first episode in the first year; and greater-than-or-equal-to 1 rejection, the first episode after the first year. A single rejection episode in the first year reduced t1/2 (45+/-11 years in those with no rejection vs. 25+/-8 years in those with 1 in the first year). Multiple rejections (t1/2=5+/-11 years) and a first rejection after the first year (t1/2=3+/-1 years) have a significant effect (P<.05). Both living and cadaver donor recipients with rejection had shortened t1/2. For those with >1 rejection, the first episode in the first year, and those with greater-than-or-equal-to 1 rejection, the first episode after the first year, chronic rejection was the predominant cause of graft loss; noncompliance also played a role. We conclude that a single rejection episode shortens t1/2. Those with >1 rejection, the first episode within the first year, and those with greater-than-or-equal-to 1 rejection, the first episode after the first year, are at high risk for late graft loss.
引用
收藏
页码:857 / 859
页数:3
相关论文
共 13 条
[1]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[2]  
BASADONNA GP, IN PRESS TRANSPLANTA
[3]  
CECKA JM, 1991, TRANSPLANT P, V23, P1263
[4]  
CHAVERS BM, IN PRESS J PEDIATR N
[5]  
FERGUSON RM, 1992, 18TH AM SOC TRANSPL, P83
[6]  
FREY DJ, 1990, CRIT CARE CLIN, V6, P899
[7]   SEQUENTIAL THERAPY - A PROSPECTIVE RANDOMIZED TRIAL OF MALG VERSUS OKT3 FOR PROPHYLACTIC IMMUNOSUPPRESSION IN CADAVER RENAL-ALLOGRAFT RECIPIENTS [J].
FREY, DJ ;
MATAS, AJ ;
GILLINGHAM, KJ ;
CANAFAX, D ;
PAYNE, WD ;
DUNN, DL ;
SUTHERLAND, DER ;
NAJARIAN, JS .
TRANSPLANTATION, 1992, 54 (01) :50-56
[8]   THE LARGE CENTER VARIATION IN HALF-LIVES OF KIDNEY-TRANSPLANTS [J].
GJERTSON, DW ;
TERASAKI, PI .
TRANSPLANTATION, 1992, 53 (02) :357-362
[9]  
GJERTSON DW, 1992, CLIN TRANSPLANTS 199, P225
[10]   THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF 1ST CADAVER KIDNEY-TRANSPLANTS [J].
GULANIKAR, AC ;
MACDONALD, AS ;
SUNGURTEKIN, U ;
BELITSKY, P .
TRANSPLANTATION, 1992, 53 (02) :323-328